Regulators Wonder if Cancer Patients ‘Need’ New Treatments

Wednesday, October 30, 2019
Authors: 
Matthew D. Mitchell

Anna Miller (Parsons) [1]

Matthew D. Mitchell and Anna Parsons write on regulatory hurdles faced in introducing a new cancer drug, despite the drug already having been approved by the FDA.

Read it at the Wall Street Journal [2].


Source URL:https://www.mercatus.org/commentary/regulators-wonder-if-cancer-patients-%E2%80%98need%E2%80%99-new-treatments

Links
[1] https://www.mercatus.org/external-people/anna-miller-parsons [2] https://www.wsj.com/articles/regulators-wonder-if-cancer-patients-need-new-treatments-11572475291

https://www.mercatus.org